RESUMO
La Ceruloplasmina (Cp) es la principal proteína transportadora de cobre en circulación. Su concentración es abundante en plasma; se considera un reactante de fase aguda y su función fisiológica no se encuentra fehacientemente establecida. Fundamentalmente se sintetiza en los hepatocitos. También se encuentra en otros tipos celulares como monocitos, astrocitos y células de Sertoli. Su concentración sérica se utiliza en el diagnóstico diferencial de enfermedad de Wilson. La concentración total en plasma se considera igual a la suma de las concentraciones de apo y holo Cp, de manera que la cantidad de esta proteína determinada por un método inmunológico no indica que la enzima se encuentre presente solamente en su forma activa. Entonces, al utilizar esta metodología, se sobreestima la proteína funcionalmente activa. Existen diversos métodos para determinar su actividad. En este trabajo se describe un método automatizado para medir su actividad ferroxidasa que utiliza iones Fe2+ como sustrato. Los valores de referencia de actividad de Cp se diferenciaron estadísticamente entre el grupo de mujeres y el de hombres, siendo de 424-796 UI/L y 397-733 UI/L, respectivamente. Además, se obtuvo una correlación significativa entre la actividad ferroxidasa y la concentración proteica (r=0,7285; p<0,0001).
Ceruloplasmin (Cp) is the principal copper carrier in human plasma. It is an abundant protein that participates in the acute phase reaction to stress, but its physiological function is unknown. Althought Cp is synthesised predominantly in the liver, other cell types express the protein, including monocytes, astrocytes and Sertoli cells. The serum concentration of the copper protein ceruloplasmin has been an important diagnostic indicator of Wilson`s disease. Measurement of the total amount of Cp protein may not reflect Cp enzyme activity in the serum. The immunologic assay may lead to overestimation of the total amount of functional Cp in the serum due to this method's capacity to determine both the functional holo Cp and non-functional apo Cp. Several methods for determining ferroxidase activity have been reported. In this study, a method is described for automated measurement of the activity. In this method, Fe2+ ions are used as the substrate. The range for serum Cp ferroxidase activity in healthy persons was 424-796 UI/L for women, and 397-733 UI/L for men. Significant correlations between serum ferroxidase activity and Cp concentration (r=0,7285; p < 0,0001) were found.
Assuntos
Humanos , Ceruloplasmina/fisiologia , Valores de Referência , Ceruloplasmina/análise , Ceruloplasmina/metabolismo , Degeneração Hepatolenticular/sangueRESUMO
Translational control is a common regulatory mechanism for the expression of iron-related proteins. For example, three enzymes involved in erythrocyte development are regulated by three different control mechanisms: globin synthesis is modulated by heme-regulated translational inhibitor; erythroid 5-aminolevulinate synthase translation is inhibited by binding of the iron regulatory protein to the iron response element in the 5'-untranslated region (UTR); and 15-lipoxygenase is regulated by specific proteins binding to the 3'-UTR. Ceruloplasmin (Cp) is a multi-functional, copper protein made primarily by the liver and by activated macrophages. Cp has important roles in iron homeostasis and in inflammation. Its role in iron metabolism was originally proposed because of its ferroxidase activity and because of its ability to stimulate iron loading into apo-transferrin and iron efflux from liver. We have shown that Cp mRNA is induced by interferon (IFN)-ã in U937 monocytic cells, but synthesis of Cp protein is halted by translational silencing. The silencing mechanism requires binding of a cytosolic inhibitor complex, IFN-Gamma-Activated Inhibitor of Translation (GAIT), to a specific GAIT element in the Cp 3'-UTR. Here, we describe our studies that define and characterize the GAIT element and elucidate the specific trans-acting proteins that bind the GAIT element. Our experiments describe a new mechanism of translational control of an iron-related protein and may shed light on the role that macrophage-derived Cp plays at the intersection of iron homeostasis and inflammation.
Assuntos
Animais , Humanos , /fisiologia , Ceruloplasmina/fisiologia , Proteínas Reguladoras de Ferro/fisiologia , Ferro/metabolismo , Biossíntese de Proteínas/fisiologia , /genética , Ceruloplasmina/genética , Regulação da Expressão Gênica/genética , Regulação da Expressão Gênica/fisiologia , Homeostase/genética , Homeostase/fisiologia , Inflamação/metabolismo , Interferon gama/metabolismo , Proteínas Reguladoras de Ferro/genética , Biossíntese de Proteínas/genética , RNA MensageiroAssuntos
Adulto , Humanos , Masculino , Feminino , Ceruloplasmina/metabolismo , Distrofias Musculares/enzimologia , Ceruloplasmina/fisiologia , Ceruloplasmina/genética , Peroxidação de Lipídeos , Creatina Quinase/sangue , Creatina Quinase , Heterozigoto , Distrofias Musculares/diagnóstico , Distrofias Musculares/genética , MutaçãoRESUMO
Se resumen los niveles séricos de Cobre (Cu) y Ceruloplasmina (Cp) en medicina general y particularmente en diversos procesos malignos y benignos. Se menciona la hipótesis que vincula las metástasis, el crecicmiento tumoral y la angiogénesis concomitante con la elevación del Cu sérico. Se mensionan los resultados obtenidos en 20 pacientes con melanoma maligno concluyendo que para el Estadio I una elevación brusca de Cu sérico obliga a pensar en una sistematización del proceso oncológico